Logiscreen

Bio-Rad Laboratories Inc - Class A

$294.32
Market Cap 7.94B
ROE 2.4%
Gross Margin 52.3%
Debt/Equity 0.2
Current Ratio 3.2
Revenue QoQ 1.1%
EPS QoQ -9.5%
F-Score 6

About

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
49.16
vs median 33.61
P/B
1.21
vs median 2.16
ROE
0.02
vs median 0.09

Decent quality with acceptable fundamentals

Mid-cap company with growth potential

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics